BRIEF-Alexion receives positive CHMP opinion for Soliris in the EU
June 23, 2017 at 08:33 AM EDT
* Alexion receives positive CHMP opinion for Soliris (eculizumab) for the treatment of patients with refractory Generalized Myasthenia Gravis (GMG) in the European Union
